FIELD: medicine.
SUBSTANCE: invention relates to medicine, obstetrics and gynaecology, biochemistry. The content of leptin and soluble leptin receptors is determined in the blood of the pregnant woman. The prognostic index (I) is calculated by the formula: I=L/RRL × 100, wherein L is the content of leptin in blood serum, ng/ml; RRL is the content of soluble leptin receptors in blood serum, ng/ml. At a value of I of 500 or more, the development of macrosomia is predicted in pregnant women with a BMI over 30 kg/m2.
EFFECT: increase in the accuracy of predicting macrosomy, accessibility of the method.
1 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FETOPLACENTAL INSUFFICIENCY PREDICTION IN PREGNANT WOMEN WITH ANDROIDS TYPE OF OBESITY | 2020 |
|
RU2738708C1 |
| METHOD FOR PREDICTION OF GESTATIONAL DIABETES MELLITUS IN FEMALES WITH ANDROIDS TYPE OF OBESITY | 2018 |
|
RU2686069C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA IN PREGNANT WOMEN WITH VARIOUS TYPES OF DIABETES MELLITUS | 2021 |
|
RU2767912C1 |
| METHOD FOR PREDICTING THE RISK OF PREECLAMPSIA IN PREGNANT WOMEN WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2751139C1 |
| METHOD FOR PREDICTION OF RISK OF GESTATIONAL DIABETES MELLITUS IN PREGNANT WOMEN | 2019 |
|
RU2716268C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF OVARIAN DYSFUNCTION AND EVALUATION OF CLINICAL EFFECTIVENESS IN ADOLESCENT GIRLS SUFFERING FROM OBESITY | 2019 |
|
RU2743728C1 |
| METHOD FOR PREDICTING FOETAL GROWTH RESTRICTION SYNDROME IN PREGNANT WOMEN WITH OBESITY | 2022 |
|
RU2785904C1 |
| METHOD FOR PREDICTING COURSE OF PREGNANCY AND CHILDBIRTH IN WOMEN WITH COMBINATION OF OBESITY AND THROMBOPHILIA | 2020 |
|
RU2751415C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
| METHOD OF PREDICTING THE RISK OF PRE-ECLAMPSIA IN PREGNANT WOMEN WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2800716C1 |
